Marshall Wace North America L.P. - AYALA PHARMACEUTICALS INC ownership

AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 14 filers reported holding AYALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of AYALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$559,000
+11.4%
49,2660.0%0.00%0.0%
Q2 2021$502,00049,2660.00%
Other shareholders
AYALA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 318,599$3,613,0001.15%
Ikarian Capital, LLC 538,939$6,112,0000.43%
SILVERARC CAPITAL MANAGEMENT, LLC 40,956$464,0000.26%
Redmile Group, LLC 667,816$7,573,0000.13%
BOOTHBAY FUND MANAGEMENT, LLC 53,784$610,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 53,000$601,0000.01%
WELLINGTON MANAGEMENT GROUP LLP 961,609$10,905,0000.00%
Marshall Wace North America L.P. 49,266$559,0000.00%
Chevy Chase Trust Holdings, LLC 15,000$170,0000.00%
Tower Research Capital LLC (TRC) 163$2,0000.00%
View complete list of AYALA PHARMACEUTICALS INC shareholders